C.R. Bard Stock Hits New 52-Week High (BCR)

NEW YORK ( TheStreet) -- C.R. Bard (NYSE: BCR) hit a new 52-week high Tuesday as it is currently trading at $112.44, above its previous 52-week high of $112.36 with 75,184 shares traded as of 10:05 a.m. ET. Average volume has been 628,500 shares over the past 30 days.

C.R. Bard has a market cap of $8.95 billion and is part of the health care sector and health services industry. Shares are up 13.7% year to date as of the close of trading on Monday.

C. R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates C.R. Bard as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full C.R. Bard Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more..
null

If you liked this article you might like

EY's Greene Sees More Med Tech, CRO Deals Ahead

Deals of the Week: Waiting for Clarity

Merger Buzz Drives Akorn to Top of Health Chart in April

Deals of the Week: Reason for Optimism

Good Medicine Makes for 3 Good Charts